Mirdametinib

Mirdametinib


Mirdametinib (PD0325901) is an orally active, selective, non-ATP-competitive MEK inhibitor (IC50: 0.33 nM). It blocks MEK1/2 activation, suppresses p-ERK1/2 expression, and induces apoptosis, demonstrating broad-spectrum anticancer activity in human tumor xenografts. Reagent grade, for research use only.

Molecular structure of the compound BP-43620
    • Unit
    • Price
    • Qty
    • 25 MG
    • $120.00
    • 50 MG
    • $210.00
    • 100 MG
    • $320.00
    • 250 MG
    • $540.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire